Visual function restoration with a highly sensitive and fast Channelrhodopsin in blind mice
Standard
Visual function restoration with a highly sensitive and fast Channelrhodopsin in blind mice. / Chen, Fei; Duan, Xiaodong; Yu, Yao; Yang, Shang; Chen, Yuanyuan; Gee, Christine E; Nagel, Georg; Zhang, Kang; Gao, Shiqiang; Shen, Yin.
In: SIGNAL TRANSDUCT TAR, Vol. 7, No. 1, 104, 18.04.2022.Research output: SCORING: Contribution to journal › Letter › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Visual function restoration with a highly sensitive and fast Channelrhodopsin in blind mice
AU - Chen, Fei
AU - Duan, Xiaodong
AU - Yu, Yao
AU - Yang, Shang
AU - Chen, Yuanyuan
AU - Gee, Christine E
AU - Nagel, Georg
AU - Zhang, Kang
AU - Gao, Shiqiang
AU - Shen, Yin
PY - 2022/4/18
Y1 - 2022/4/18
N2 - Inherited and age-related retinal degenerative diseases cause progressive loss of photoreceptors, ultimately leading to blindness. Optogenetics is a promising strategy for restoring visual function through photosensitive proteins’ ectopic expression in surviving retinal neurons. Very recently, the optogenetic method with a red-shifted Channelrhodopsin was clinically applied for partial recovery of visual function in a blind patient. However, major obstacles to achieving optimal optogenetic vision restoration are either the low light sensitivity or the slow kinetics of existing rhodopsin-based optogenetic tools, which can be improved by molecular engineering to enhance the efficacy of fast Channelrhodopsins (ChRs). Here, we present a newly engineered ChR variant PsCatCh2.0, engineered from PsChR, which displays inherently high Ca2+ and Na+ conductance and fast kinetics.
AB - Inherited and age-related retinal degenerative diseases cause progressive loss of photoreceptors, ultimately leading to blindness. Optogenetics is a promising strategy for restoring visual function through photosensitive proteins’ ectopic expression in surviving retinal neurons. Very recently, the optogenetic method with a red-shifted Channelrhodopsin was clinically applied for partial recovery of visual function in a blind patient. However, major obstacles to achieving optimal optogenetic vision restoration are either the low light sensitivity or the slow kinetics of existing rhodopsin-based optogenetic tools, which can be improved by molecular engineering to enhance the efficacy of fast Channelrhodopsins (ChRs). Here, we present a newly engineered ChR variant PsCatCh2.0, engineered from PsChR, which displays inherently high Ca2+ and Na+ conductance and fast kinetics.
U2 - 10.1038/s41392-022-00935-x
DO - 10.1038/s41392-022-00935-x
M3 - Letter
C2 - 35430811
VL - 7
JO - SIGNAL TRANSDUCT TAR
JF - SIGNAL TRANSDUCT TAR
SN - 2095-9907
IS - 1
M1 - 104
ER -